-
funded by National Institutes of Health and Bill & Melinda Gates Foundation. Dr. Xiao’s research team focuses on female reproductive toxicology, organ-on-chip, and non-hormonal female contraception
-
compliance with National Institutes of Health certification (e.g., ensure that effort is in line with what was proposed, and with budget projections). Handles and tracks purchasing and travel requests
-
Training And Research in New Jersey (LHS STAR NJ); NCATS UL1: National Institutes of Health, New Jersey Alliance for Clinical and Translational Science (NJ ACTS); as well as activities of the Rutgers Network
-
Training And Research in New Jersey (LHS STAR NJ); NCATS UL1: National Institutes of Health, New Jersey Alliance for Clinical and Translational Science (NJ ACTS); as well as activities of the Rutgers Network
-
philanthropies and private organizations. CSHP’s diverse funding portfolio includes the National Institutes of Health, the Agency for Healthcare Research & Quality, the NJ Department of Human Services, the NJ
-
effort on research projects in compliance with National Institutes of Health certification (e.g., ensure that effort is in line with what was proposed, and with budget projections). Handle and track
-
Institutional Research Boards (IRB) to ensure compliance with the National Institute of Health (NIH), Food and Drug Administration (FDA), and other standards for recombinant DNA and vaccine research, as
-
protocol compliance per Food and Drug Administration (FDA), National Institutes of Health (NIH), Code of Federal Regulations (CFR), Good Clinical Practice (GCP) guidelines, Office for Human Research
-
), Food and Drug Administration (FDA), and National Institutes of Health (NIH), International Air Transport Association (IATA) requirements and guidelines for bio-specimen handling and storage. Ensures
-
(GLP), Food and Drug Administration (FDA), and National Institutes of Health (NIH), International Air Transport Association (IATA) requirements and guidelines for bio-specimen handling and storage